COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,780 Articles (22,946 medRxiv, 8,834 bioRxiv)

Most recent first Previous |  Page 1215: Articles 12141-12150  | Next

A biological variation-based approach to the day-to-day changes of D-dimer, Fibrinogen, and Ferritin levels that are crucial in the clinical course of COVID-19 in healthy smokers and non-smokers
MENEKSE, E., DUZ, M. E., BALCI, A.
10.1101/2021.10.24.21265444 — Posted: 2021-10-26
Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants
Holmdahl, I., Kahn, R., Slifka, K. J., Dooling, K., Slayton, R. B.
10.1101/2021.10.25.21265493 — Posted: 2021-10-26
Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study
Edward, P. R., Lorenzo-Redondo, R., Reyna, M. E., Simons, L. M., Hultquist, J. F., Patel, A. B., Ozer, E. A., Mullerr, W. J., Heald-Sargent, T., McHugh, M., Dean, T. J., Dalal, R. M., John, J., Manz, S. C., Kociolek, L. K.
10.1101/2021.10.23.21265402 — Posted: 2021-10-26 Discussion: Offsite
Ongoing use of SSRIs and the hospital course of COVID-19 patients: a retrospective outcome analysis
Rauchman, S. H., Mendelson, S. G., Rauchman, C., Kasselman, L. J., Pinkhasov, A., Reiss, A. B.
10.1101/2021.10.25.21265218 — Posted: 2021-10-26
Immunoprecipitation-targeted proteomics assays facilitate rational development of SARS-CoV-2 serological diagnostics
Fu, Z., Rais, Y., Drabovich, A.
10.1101/2021.10.25.21265408 — Posted: 2021-10-26
Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections
Taquet, M., Dercon, Q., Harrison, P. J.
10.1101/2021.10.26.21265508 — Posted: 2021-10-26 Discussion: Onsite | Offsite
Optimizing Social Distancing Policies: A Dynamic Programming Approach for Coupled High and Low Risk Populations
Dai, P., Vardavas, R., Nowak, S. A., Suen, S.-c.
10.1101/2021.10.24.21265170 — Posted: 2021-10-26
Clinical performance characteristics of the Swift Normalase Amplicon Panel for sensitive recovery of SARS-CoV-2 genomes
Shrestha, L., Lin, M. J., Xie, H., Mills, M. G., Bakhash, S. A. M., Gaur, V. P., Livingston, R. J., Castor, J., Bruce, E. A., Botten, J. W., Huang, M.-L., Jerome, K. R., Greninger, A. L., Roychoudhury, P.
10.1101/2021.10.22.21265255 — Posted: 2021-10-26
Leveraging machine learning and self-administered tests to predict COVID-19:An olfactory and gustatory dysfunction assessment through crowd-sourced data in India
Kumar, R., Singh, M., Singh, P., Parma, V., Ohla, K., Olsson, S. B., Saini, V., Rani, J., Kishore, K., Kumari, P., Ichhpujani, P., Sharma, A., Kumar, S., Sharma, M., Bhondekar, A. P., Kothari, A., Sardana, V., Iyengar, S., Dash, D., Kaur, R.
10.1101/2021.10.20.21265247 — Posted: 2021-10-26
ABO blood group type does not influence the level of SARS-CoV-2 antibody response in convalescent plasma donors
Ziberna, K., Jazbec, K., Jez, M., Mali, P., Rahne Potokar, U., Rozman, P.
10.1101/2021.10.19.21265195 — Posted: 2021-10-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).